|
Re: Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study (BRD4i)
|
5
|
Resverlogix Corp.
|
Sep 21, 2018 10:53AM
|
|
Re: Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
5
|
Resverlogix Corp.
|
Apr 13, 2020 05:08PM
|
|
Re: The waiting game.....
|
5
|
Resverlogix Corp.
|
Jan 23, 2019 10:41PM
|
|
Re: Novartis Phase III study shows Canakinumab reduces MACE events
|
5
|
Resverlogix Corp.
|
Jun 22, 2017 11:46AM
|
|
Re: Strong Movement Today
|
5
|
Resverlogix Corp.
|
Sep 01, 2015 04:43PM
|
|
Re: Reconciliation of comments made
|
5
|
Resverlogix Corp.
|
Oct 31, 2016 05:09PM
|
|
Re: aberaterone
|
5
|
Zenith Epigenetics
|
Jun 25, 2018 12:12PM
|
|
ZEN003694 Trial Now Listed on ClinicalTrials.gov
|
5
|
Zenith Epigenetics
|
Mar 10, 2016 09:29AM
|
|
Re: Slides are up
|
5
|
Resverlogix Corp.
|
Oct 17, 2017 02:33PM
|
|
Re: Trial
|
5
|
Zenith Epigenetics
|
Sep 07, 2016 09:34AM
|
|
Re: Vitamin D and Omega 3 don’t preserve renal fxn in Type 2 DM
|
5
|
Resverlogix Corp.
|
Nov 12, 2019 10:52AM
|
|
A few musings
|
5
|
Resverlogix Corp.
|
May 02, 2017 02:58PM
|
|
Slide Deck is Posted
|
5
|
Resverlogix Corp.
|
Oct 31, 2019 08:05PM
|
|
Re: 2019 Potential Events
|
5
|
Resverlogix Corp.
|
May 20, 2019 12:18PM
|
|
Re: Why did we not get the announcment today that RVX will be presenting for CVD
|
5
|
Resverlogix Corp.
|
Oct 11, 2019 09:29PM
|
|
Re: NFK meeting
|
5
|
Resverlogix Corp.
|
Feb 20, 2020 01:41PM
|
|
Re: Clayton no longer with the company....
|
5
|
Resverlogix Corp.
|
May 17, 2018 09:25PM
|
|
Re: COVID 19 & BP
|
5
|
Resverlogix Corp.
|
Jun 27, 2020 10:25PM
|
|
Re: Whatever happened to the update on our trial? Stalled like everything else here.
|
5
|
Resverlogix Corp.
|
Apr 23, 2020 09:03PM
|
|
Re: Celebration meeting proposal!
|
5
|
Resverlogix Corp.
|
Sep 27, 2019 07:56PM
|
